trial · primary record
ADI-270
Clear Cell Renal Cell Carcinoma
| Phase | Phase 1 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2025-07-22 |
| Primary endpoint | The Incidence of Subjects with Dose Limiting Toxicities within each dose level cohort |
| Registry ID | NCT06480565 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:47.048Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06480565
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.